Model collapse AI training data risk grows as Meta’s Brand Memory ad tools flood the open web with synthetic content, ...

Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...

Today, the industry has edged closer to production. But the biggest challenge to widespread deployment is no longer ...